MedTrace Logo

Effect of Influenza Vaccination on Donor Egg Recipient Outcomes

NCT02946177 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2020-02-18

No results posted yet for this study

Summary

In this study the investigators propose a randomized controlled trial to evaluate the effect of influenza vaccination on clinical pregnancy rates among women undergoing in vitro fertilization as donor egg recipients.

Conditions

Interventions

BIOLOGICAL

Influenza Vaccine

Inactivated influenza vaccine indicated for immunization against disease caused by influenza virus subtype A and type B present in the vaccine. Approved for use in persons 5 years of age and older. Single Dose prefilled 0.5 ml syringe.

OTHER

Sterile Saline

0.5 mL of sterile Saline administered im

Sponsors & Collaborators

  • Foundation for Human Reproduction

    collaborator UNKNOWN

  • Center for Human Reproduction

    lead OTHER

Principal Investigators

  • David H Barad, MD, MS · Director of Assisted Reproductive Technology

  • Norbert Gleicher, MD · Medical Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-19
Primary Completion
2020-12-31
Completion
2021-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02946177 on ClinicalTrials.gov